Post-IPO Equity - Terns Pharmaceuticals - Dec 20, 2022 Funding Round Profile - Cointime

Bitcoin $98,465.04 +1.01%
Ethereum $3,338.98 -0.21%
BNB $625.90 +0.73%
Optimism $2.17 +19.09%
Arbitrum $0.80 +7.23%
Solana $258.62 +5.83%
Polygon $0.47 +3.34%
Cosmos $7.01 +8.90%
Avalanche $38.74 +9.91%

Bitcoin $98,465.04 +1.01%
Ethereum $3,338.98 -0.21%
BNB $625.90 +0.73%
Optimism $2.17 +19.09%
Arbitrum $0.80 +7.23%
Solana $258.62 +5.83%
Polygon $0.47 +3.34%
Cosmos $7.01 +8.90%
Avalanche $38.74 +9.91%

Terns Pharmaceuticals

company

Funding Round

Post-IPO Equity

Money Raised

$ 86.30M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion

Historical Financing

Announced Date	Round	Money Raised	Investors
Aug 12, 2022	Post-IPO Equity	$ 65M	Fairmount Funds Management,Venrock Healthcare Capital Partners	Detail
Oct 30, 2018	Series B	$ 80M	Decheng Capital,Lilly Asia Ventures,etc.	Detail
Jan 5, 2021	Series C	$ 87M	Deepfield,Eli Lilly,etc.	Detail
Apr 4, 2018	Series A	$ 30M	Lilly Asia Ventures	Detail
Feb 4, 2021	IPO	$ 127.50M		Detail